Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesObstetrics/GynecologyHighmark Blueshield Neny preventive coverage updat…
    Ask Trek AI about this page
    CurrentHighmark Blueshield NenyPolicy N/A

    Women's Preventive Health Services Addendum (West Virginia)

    Customize your policy alerts

    Sign up for all Highmark Blueshield Neny policy alerts

    Know when Highmark Blueshield Neny releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines covered women's preventive services, screening, counseling, and contraceptive benefits for Highmark West Virginia members; applies to providers delivering well-woman, prenatal/postpartum, and contraceptive care under the payer's preventive health guidelines.

    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyWomen's Preventive Health Services Addendum (West Virginia)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateN/A
    Key ActionRequest an online formulary exception for nonformulary contraceptive drugs when medical necessity is documented; no fail‑first is required.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    up to 4wellness visits annually
    ages 15+HIV screening (once lifetime)
    24-28 wksgestational diabetes timing
    2 annuallypostpartum diabetes rescreen
    18 methodscovered contraceptive categories

    Coverage Criteria — Women's Preventive Services

    Well-woman visits

    Covered preventive visits and scope

    Well-woman visit allowance: Up to four wellness visits annually for women: two visits with a Primary Care Physician and two visits with an Obstetrician/Gynecologist with a routine diagnosis.up to 4 per year

    Initial visit to determine pregnancy defined by E&M procedure codes 99201-99215 when accompanied by appropriate diagnosis codes (e.g., amenorrhea and pregnancy diagnosis).

    HIV screening and counseling

    Screening and counseling coverage

    HIV screening/counseling: Counseling for HIV infection for all sexually active women; up to two counseling sessions per year; screening at least once for ages 15 and older; risk assessment and prevention education beginning at age 13; screen all pregnant women at initiation of prenatal care with rescreening during pregnancy based on risk factors.ages 13+ risk assessment; ages 15+ at least once lifetime screening

    Use counseling codes 99401-99404 and screening tests with routine diagnosis codes as described in policy.

    Breastfeeding counseling and supplies

    Counseling and DME coverage

    Breastfeeding counseling is covered with codes 99401, 99402, or 99403 when accompanied by diagnosis Z39.1.per guideline

    Breast pumps (manual E0602 and electric E0603) and supplies (A4281–A4286; A4287 effective 1/1/2024; A4288 effective 10/1/2025) are covered as durable medical equipment and require a prescription.

    Gestational and postpartum diabetes screening

    Timing and coding conditions for diabetes screening in pregnancy and postpartum

    Gestational diabetes screening: Screen for diabetes in pregnancy at the first prenatal visit and at 24–28 weeks of gestation.timing specified

    Use glucose test procedure codes 82947, 82950, 82951, 82952 or 83036 when accompanied by a pregnancy diagnosis.

    Postpartum diabetes screening: Women with a history of gestational diabetes who are not currently pregnant and have no prior diagnosis of diabetes should be screened postpartum; initial testing ideally within the first year postpartum and can be conducted as early as 4–6 weeks.initial within 4–52 weeks postpartum; rescreen every 3 years for minimum 10 years

    When no pregnancy and no prior diabetes diagnosis, code with Z86.32 or Z87.59 plus procedure codes 82947, 82950, 82951, 82952, or 83036; policy notes frequency as 2 annually and rescreen interval of at least every 3 years for 10 years.

    Urinary incontinence and anxiety screening

    Annual screening recommendations

    Urinary incontinence screening: Screen women annually for urinary incontinence as part of well-woman visits, assessing whether involuntary leakage of urine impacts activities and quality of life.annual

    Urinary incontinence is defined as involuntary leakage of urine (e.g., with coughing or sneezing).

    Anxiety screening: Recommend screening for anxiety in adolescent and adult women, including pregnant and postpartum women, with referral for further evaluation and treatment when indicated.per guideline

    Recommendation sourced from the Women's Preventive Services Initiative as noted in the addendum.

    Contraceptive methods coverage

    Coverage stance for contraceptives

    Contraceptive coverage: FDA-approved contraceptive methods, including sterilization and procedures as prescribed, and one or more forms from each of the 18 FDA‑approved method categories are covered without cost sharing when medically appropriate as determined by the provider.no cost sharing for covered methods

    Providers may request an exception for prescribed nonformulary contraceptive drugs via the online request form for medical necessity; an initial 'Fail First' is not required when medical necessity is documented. Only FDA‑approved contraception apps are reimbursable and require a paper claim submission with receipt and provider prescription.

    Coverage of non‑FDA‑approved contraception apps is not described in this addendum. Only FDA‑approved contraception apps are eligible for reimbursement, and they must be submitted via the paper claim process. Members must provide three items for reimbursement: (1) the completed paper medical claim form with "contraception app purchase" entered in the diagnosis section, (2) the receipt of payment for the FDA‑approved contraception app, and (3) a provider prescription for the FDA‑approved contraception app. Providers may request an exception for prescribed nonformulary contraceptive drugs due to medical necessity using the online formulary exception request; when approved the prescribed drug will be made available with zero‑dollar cost share. An initial "Fail First" is not required for contraceptive formulary exceptions when medical necessity is documented.

    Coding — Procedure and Diagnosis Codes

    Well-woman, counseling and initial pregnancy visit codesCPTCovered
    99201-99215E&M procedure codes for initial visit to determine pregnancy when accompanied by amenorrhea and pregnancy diagnosis
    G0445STI counseling (up to two sessions per year) when accompanied by a routine diagnosis
    99401, 99402, 99403, 99404HIV counseling codes when accompanied by HIV counseling diagnosis code
    DME breast pump and suppliesHCPCSCovered
    E0602, E0603Breast pump (manual and electric)
    A4281, A4282, A4283, A4284, A4285, A4286, A4287, A4288Breast pump supplies (A4287 effective 1.1.2024; A4288 effective 10.1.2025)
    Diabetes screening codesCPTCovered
    82947, 82950, 82951, 82952, 83036CPT/Procedure codes for glucose testing (gestational and postpartum diabetes screening)
    ICD-10 codes for postpartum diabetes screening contextICD-10
    Z86.32, Z87.59History of gestational diabetes/related diagnosis codes used when no pregnancy diagnosis and no prior diabetes diagnosis
    HPV screening codesCPTCovered
    87623, 87624, 87625HPV testing codes (recommended every 3 years for women 30+ with normal Pap)
    inv-13: HIV screening initiation age
    Risk assessment start ageBegin HIV risk assessment and prevention education at age 13
    Lifetime screening recommendationPerform at least one HIV screening test during the lifetime for individuals age 15 and older
    Pregnancy screeningScreen all pregnant women for HIV at initiation of prenatal care; rescreen during pregnancy based on risk factors
    Counseling frequency and codesUp to two HIV counseling sessions per year using codes 99401–99404 when accompanied by an HIV counseling diagnosis code
    inv-14: Postpartum diabetes rescreen interval

    Provider Actions — Authorization, Documentation, and Billing

    Prior Authorization

    Contraceptive formulary exception process

    FDA-approved contraceptive methods are covered without cost sharing. Providers may request an exception for prescribed non-formulary contraceptive drugs for medical necessity by completing the online pharmacy exception form: https://providers.highmark.com/resources-and-education/forms/pharmacy-prior-authorization-forms

    • Exception requests do NOT require an initial fail‑first or step-therapy attempt — provider-determined medical necessity alone is sufficient.
    • If approved, the drug is available to the member with a zero-dollar cost share.
    Step Therapy

    Fail-first not required for contraceptive exception

    An initial 'Fail First' (step-therapy) is not required for contraceptive formulary exception requests. Providers may note prior treatment failures on the exception form, but documenting a failed formulary trial is optional and not a condition of approval.

    Background

    This addendum summarizes Highmark West Virginia's covered women's preventive services, aligning benefits to age, pregnancy status, and visit type. It confirms coverage for FDA‑approved contraceptive methods (including sterilization and procedures) across the 18 FDA‑recognized method categories without cost sharing when medically appropriate, and describes the exception process for prescribed nonformulary contraceptive drugs. It also explains reimbursement requirements specific to FDA‑approved contraception apps and provides instructions for provider and member documentation needed to obtain reimbursement.

    Definitions

    inv-21: Urinary incontinence
    DefinitionInvoluntary leakage of urine (e.g., with coughing or sneezing)
    Screening frequencyScreen women annually for urinary incontinence as part of well-woman visits
    Assessment focusAssess whether incontinence occurs and whether it impacts activities and quality of life
    Policy Summary
    PayerHighmark Blueshield Neny
    PolicyWomen's Preventive Health Services Addendum (West Virginia)
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateN/A
    Key ActionRequest an online formulary exception for nonformulary contraceptive drugs when medical necessity is documented; no fail‑first is required.
    SourceLink
    On This Page
    Coverage Criteria — Women's Preventive ServicesCoding — Procedure and Diagnosis CodesProvider Actions — Authorization, Documentation, and BillingBackgroundDefinitions
    Initial postpartum testing timingInitial testing ideally within the first year postpartum; can be conducted as early as 4–6 weeks postpartum
    Rescreen intervalRescreen at least every 3 years for a minimum of 10 years after the pregnancy
    Testing after positive resultIf postpartum screening is positive, perform confirmatory diagnostic testing regardless of the initial test (e.g., OGTT, fasting plasma glucose, or hemoglobin A1c)
    Coding when no pregnancy/diabetes diagnosisUse diagnosis Z86.32 or Z87.59 with procedure codes 82947, 82950, 82951, 82952, or 83036; frequency: 2 annually
    Billing Rule

    Contraception app reimbursement documentation

    Only FDA-approved contraception apps that are downloadable to a mobile device are reimbursable and require a prescription plus documentation submitted by the member via paper claim.

    • Member must submit all three documents: 1) Completed Highmark Paper Medical Claim Form with "contraception app purchase" written in the Diagnosis/Nature of Illness or Injury field (https://www.highmarkbcbs.com/redesign/pdfs/mhs/Medical_Claim_Form.pdf).
    • 2) Receipt showing payment for the FDA‑approved contraception app.
    • 3) Provider prescription for the FDA‑approved contraception app.
    • Reimbursement is processed through the paper claim process only.
    Documentation Required

    Coding-linked documentation

    Link provider billing and clinical documentation to applicable coding and claim fields to avoid denials. For contraception apps, enter the phrase "contraception app purchase" in the Diagnosis or Nature of Illness or Injury field on the paper claim form; include the receipt and the prescription as supporting documentation.

    • Ensure the claim includes the provider prescription and that the member's receipt clearly identifies the app purchase and amount paid.
    • For contraceptive drug exceptions, include clinical rationale and any relevant diagnosis codes on the online exception form to support medical necessity.
    Denial Risk

    Potential denial if exception or documentation not provided

    Failure to provide the required exception approval or supporting documentation (prescription, receipt, completed paper claim with the required diagnosis text) may result in denial of reimbursement or cost sharing for the service/product.

    • For app reimbursement, missing any of the three required documents will delay or deny payment.
    • For formulary exceptions, incomplete medical-necessity rationale or missing required information on the online form may delay review or result in denial.